AZN vs SFBS · P/E 28, $288.38B cap vs P/E 14, rev $491.4M
AstraZeneca PLC (AZN) versus ServisFirst Bancshares Inc (SFBS) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
ServisFirst Bancshares Inc (SFBS) is a banks - regional company listed on NYSE.
AZN does not have a complete income-statement cache yet.
Latest reported SFBS revenue for 2026-06-30 was $491.4M. Net income was $168.8M. SFBS currently screens at market cap $4.36B and trailing P/E 13.5.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. SFBS currently screens at market cap $4.36B and trailing P/E 13.5.
Not investment advice. Open the AZN and SFBS stock pages for the full models.
Not investment advice.